ArticleApplied microbiology and biotechnology2025
Probiotic potential and antimicrobial efficacy of a dairy isolate, Enterococcus faecium MBBL3.
Article in Applied microbiology and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- Probiotics as Sustainable Alternatives to Mitigate Antibiotic Resistance in Bovine Mastitis Management.Probiotics and antimicrobial proteins · 2026Review
- Draft genome sequence ofMicrobiology resource announcements · 2026Article
- Integrated Phenotypic and Whole-Genome Analysis ofMicroorganisms · 2026Article
- Genome data mining of four probioticData in brief · 2026Article
- Genomic Insights Into Antimicrobial Resistance and Virulence of Enterococcus avium Strains From Bovine Mastitis in Some Selected Dairy Farms of Bangladesh.Veterinary medicine and science · 2026Article
- Isolation and genetic analysis of anBiochemistry and biophysics reports · 2026Article
- Draft genome sequence and annotations of the mastitis-associated multidrug-resistantMicrobiology resource announcements · 2026Article
- Prevalence, Virulence, and Pathogenic Mechanisms of Mastitis-AssociatedVeterinary sciences · 2026Review
- Draft genome sequencing of anMicrobiology resource announcements · 2026Article
- Antimicrobial resistance and virulence of Enterococcus faecium isolates from a traditionally fermented dairy beverage from Uganda.BMC microbiology · 2026Article
- Deciphering the Genomic Traits of Multi-Enterocin-ProducingMicroorganisms · 2025Article
- Draft genome sequence of multidrug-resistantMicrobiology resource announcements · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Enterococcus faecium is a promising probiotic with potential antimicrobial effects. This study aimed to evaluate the probiotic and antimicrobial properties of E. faecium MBBL3, isolated from healthy cow milk, against bovine mastitis pathogens Klebsiella pneumoniae MBBL2 (Kp MBBL2) and Escherichia coli MBBL4 (Ec MBBL4), using comprehensive genomic and functional analyses. The genome assembly and functional annotations of MBBL3 unveiled many important probiotic traits, and comparative genomic analysis demonstrated its high degree of genetic similarity with other Enterococcus strains. MBBL3 exhibited the ability to ferment a diverse range of carbohydrates and possessed 76 genes linked to carbohydrate-active enzyme, including five key CAZy families with potential antimicrobial activity. Additionally, MBBL3 harbored genes essential for bile salt and acid tolerance, stress resistance, and surface adhesion. Furthermore, MBBL3 was found to harbor gene clusters encoding secondary metabolites with antimicrobial potentials. Safety evaluations revealed a low pathogenic potential, while in-vitro assays demonstrated antibiotic susceptibility and a reduction in the growth of Kp MBBL2 and Ec MBBL4, respectively. It's bacteriocin Enterolysin_A exhibited strong molecular interactions with virulence-associated proteins of the mastitis pathogens. Thus, the promising probiotic potential and antimicrobial activity of E. faecium MBBL3, particularly against mastitis-related pathogens coupled with its safety profile, render it a promising candidate for further investigation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.